Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute

Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute

Submitted by admin on March 17, 2022 - 10:25am
Source: 
Reuters
News Tags: 
Biogen
Mylan
Tecfidera
patents
multiple sclerosis
MS
Headline: 
Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute
snippet: 

A divided U.S. appeals court on Wednesday rejected a request by Biogen Inc to reconsider a decision knocking out part of a key patent for Biogen's multiple sclerosis drug Tecfidera.

Do Not Allow Advertisers to Use My Personal information